High Ceiling / Loop Diuretics

Menu
Loop Diuretics
  • Introduction
  • Mechanism of action:
    • inhibition of NaCl reabsorption in the thick ascending limb of the loop of Henle
      •  inhibit the Na/K/2Cl transport system in the luminal membrane
        1. reduction in sodium chloride reabsorption
        2. decreases normal lumen-positive potential (secondary to potassium recycling)
        3. Positive lumen potential: drives divalent cationic reabsorption (calcium magnesium)
        4. Therefore, loop diuretics increase magnesium and calcium excretion.
          • hypomagnesemia may occur in some patients.
          • hypocalcemia does not usually develop because calcium is reabsorbed in the distal convoluted tubule.
            • {in circumstances that result in hypercalcemia, calcium excretion can be enhanced by administration of loop diuretics with saline infusion}
    • Since a significant percentage of filtered NaCl is absorbed by the thick ascending limb of loop of Henle, diuretics acting at this site are highly effective
  • Loop diuretics--Properties: rapidly absorbed following oral administration (may be administered by IV)
    • acts rapidly
    • eliminated by a renal secretion and glomerular filtration (half-life -- depend on renal function)
    • co-administration of drugs that inhibit weak acid secretion (e.g. probenecid or indomethacin) may alter loop diuretic clearance.
    • Other effects:
      •  Furosemide: increases renal blood flow; blood flow redistribution within the renal cortex
      •  Furosemide decreases pulmonary congestion and the left ventricular filling pressure in congestive heart failure (CHF) -- prior to an increase in urine output.
  • Clinical Uses:
    • Major uses:
    • Other uses:
      •  Reduction of Intracranial Pressure
      •  hyperkalemia:
        • loop diuretics increase potassium excretion
        • effect increased by concurrent administration of NaCl and water.
      •  acute renal failure:
        • may increase rate of urine flow and increase potassium excretion.
        • may convert oligouric to non-oligouric failure {easier clinical management}
        • renal failure duration -- not affected
      •  anion overload:
        • bromide, chloride, iodide: all reabsorbed by the thick ascending loop:
        • systemic toxicity may be reduced by decreasing reabsorption
          • concurrent administration of sodium chloride and fluid is required to prevent volume depletion
  •  Toxicity:
    •  Hypokalemia metabolic alkalosis:
      • increased delivery of NaCl and water to the collecting duct increases potassium and proton secretion-- causing a hypokalemic metabolic alkalosis
      • in managed by potassium replacement and by ensuring adequate fluid intake
    • Ototoxicity:
      • dose-related hearing loss (in usually reversible)
      • ototoxicity more common:
        • with decreased renal function
        • with concurrent administration of other ototoxic drugs such as aminoglycosides
    • Hyperuricemia:
      • may cause gout
      • loop diuretics cause increased uric acid reabsorption in the proximal tubule, secondary to hypovolemic states.
    • Hypomagnesemia: loop diuretics cause:
      1. reduction in sodium chloride reabsorption
      2. decreases normal lumen-positive potential (secondary to potassium recycling)
      3. Positive lumen potential: drives divalent cationic reabsorption (calcium magnesium)
      4. Therefore, loop diuretics increase magnesium and calcium excretion.
        • hypomagnesemia may occur in some patients.
        • reversed by oral magnesium administration
    • Allergic reactions:
      • furosemide: skin rash, eosinophilia, interstitial nephritis(less often)
    • Other toxicities:
      • Dehydration (may be severe)
      • hyponatremia (less common than with thiazides thought may occur in patients who increased water intake in response to a hypovolemic thirst)
      • Hypercalcemia may occur in severe dehydration and if a hypercalcemia condition {e.g. oat cell long carcinoma} is also present.

return to main menu

Ives, H.E., Diuretic Agents, in: Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 242-259.